PureCycle Technologies, Inc. PCT Reclassification Of Liability Classified Warrants To Equity

Reclassification Of Liability Classified Warrants To Equity at other companies

CoreWeave, Inc. CRWV

$0-100%

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

HTF

Heartflow, Inc. Common StockHTFL

$16.18M—

IonQIONQ

$7.14M-34.8%

Cipher Digital, Inc. CIFR

$184.25M—

Aeva TechnologiesAEVA

$29.26M+114%

Other financials

Income statement

See full

Revenue$4.1M+161%

Operating income-$41.8M-10.8%

Net income-$33.4M-479%

EPS (diluted)-$0.21-520%

Balance sheet

See full

Cash & equivalents$90.2M+301%

Total debt$68.9M+27.6%

Total equity$7.4M-96.9%

Total assets$886.0M+12.5%

Cash flow

See full

Operating cash flow-$42.7M-9.7%

CapEx$3.4M-77.1%

Free cash flow-$46.1M+14.5%

Valuation

See full

Market cap$1.61B-24.5%

Profitability

See full

Operating margin-1,701.6%-763pp

Net margin-2,062.4%-937pp

FCF margin-1,612.6%-752pp

Returns & leverage

See full

Return on equity-183.1%-443pp

Debt / equity9.3×+9.1×

Current ratio1.7×+1.2×

Where this comes from

Reported directly by PureCycle Technologies, Inc. in its filing.

Tagged under the XBRL concept pct:ReclassificationOfLiabilityClassifiedWarrantsToEquity.

The official record: PureCycle Technologies, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about PureCycle Technologies, Inc.'s reclassification of liability classified warrants to equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PureCycle Technologies, Inc.'s reclassification of liability classified warrants to equity?: PureCycle Technologies, Inc. (PCT) reported reclassification of liability classified warrants to equity of $81K in Q4 2024.
What does reclassification of liability classified warrants to equity mean?: This represents the accounting transfer of warrant obligations from liabilities to equity when specific criteria for equity classification are met. It indicates a change in the financial risk profile of the company's derivative instruments and their impact on the balance sheet.